Planet uses over 150 of its satellites in orbit and powerful AI to image the entire Earth every day, making global change visible, accessible, and actionable.
Atomwise delivers breakthrough products for pharma and agriculture companies with novel AI for atom-by-atom chemistry.
Desktop Metal is reinventing the way design and manufacturing teams print with metal, with high-speed, low-cost, drop-in-ready 3D metal printing for the most demanding mission critical applications.
Element AI is the platform that helps organizations embrace an AI-First world for today and tomorrow.
Pivot Bio transforms the $212 billion fertilizer industry with clean, energy efficient, computationally tailored biological replacements for chemical fertilizer, driven by their proprietary AI for understanding the crop microbiome behind the planet’s staple crops.
Rocket Lab, with multiple satellites successfully launched to orbit, delivers a range of complete rocket systems and technologies for fast and low-cost payload deployment. Space is open for business
Karius transforms infectious disease treatment by delivering hypothesis-free detection of almost every human pathogen, from a single standard blood draw, in less than a business day.
Illumio stops cyber threats by dynamically enforcing segmentation and policy on every point of compute and storage, on premise or in the cloud, with lights-out, hands-free management.
Plenty uses next-generation agronomics, AI-powered monitoring and control, and robotics to grow crops in a pesticide- and GMO-free environment at hundreds of times the efficiency for land-use and water of outdoor farms.
Tala uses AI and unique data science to provide instant loans over mobile phones to the underserved and unbanked around the globe.
Embark transforms the safety, efficiency, and costs of the $1 trillion global long haul trucking market with autonomous trucks capable of reasoning their way along the roads like human drivers, no expensive and laborious pre-mapping required.
Zymergen is the world’s first industrial scale Molecular Manufacturing™ company, uniting AI, robotic labs, and proprietary insights into multiple classes of microorganisms to deliver novel products and materials at global customer scale through the power of biology.
Recursion discovers transformative new life science treatments by applying breakthrough AI and computer vision to understand the behavior of millions of living human cells in parallel, every hour, every day.
Vicarious is an artificial intelligence company that uses the computational principles of the brain to develop general intelligence for robots
SentinelOne is the only platform that is proven to defend every endpoint against every type of attack, at every stage in the threat lifecycle, using behavioral-based detection with automatic mitigation and forensics.
Mythic delivers a semiconductor chip that enables data-center-scale AI at the edge of the network, in IoT and mobile applications, at ultra-low-power.
Backing Brilliant Deep Tech Teams Solving the World’s Hardest Problems
For over twenty years, DCVC and its principals have backed brilliant entrepreneurs applying Deep Tech, from the earliest stage and beyond, to transform global scale industries. Together, we have created tens of billions of dollars of value while also making the world a markedly better place.
Strengthening our commitment to Deep Tech with a new $725m fund
StarkWare Raises $30M Series A to Build Post-Quantum Secure Blockchain
DCVC has made a strong commitment to StarkWare’s $30M Series A to support their zero knowledge proofs platform for dramatically improved blockchain scalability and security.
More Productive Farmers, a Cleaner World, $212 Billion a Year of Revenue on the Table
Pivot Bio Raises $100m Series C: Bringing Microbes to Millions...of Acres
Caption Health Secures FDA Authorization for First-in-Class AI-Guided Medical Ultrasound
The FDA granted De Novo FDA authorization for a new device under its Breakthrough Device program. That device, DCVC portfolio company Caption Health’s lead product, Caption Guidance, uses artificial intelligence (AI) to put the power of ultrasound in the hands of a wide range of healthcare professionals – even those without any prior ultrasound experience.
DCVC leads $60 million Series B investment in Recursion Pharmaceuticals: Machine Vision & Robotics to Accelerate Drug Discovery
While common diseases like diabetes and heart disease draw widespread attention and treatment, rare diseases that most...
John Deere acquires Blue River Technology for $305 million, bringing full stack AI to agriculture
Congratulations to Blue River Technology co-founders Jorge Heraud and Lee Redden, CEO and CTO, and their deeply talented and dedicated...
DCVC Portfolio IPO: Elastic goes public, opening at a $4.4 billion valuation
We’re excited to announce that Elastic went public today at a $4.4 billion valuation. DCVC’s early investment in Elastic in its 2012 Series A financing built on our pioneering thesis at the intersection of open-source, big data infrastructure, and scale-out compute, which began with one of our founders seeding XenSource (the foundation of both AWS and Microsoft Azure) in 2004.